Treatment of PDE-ALDH7A1 in Current Perspectives and Questions

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section focuses on treatment options.

Biomarkers and their Potential for Newborn Screening in Current Perspectives and Questions

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section talks about biomarkers and newborn screening.

Biochemistry and Genetics in Current Perspectives and Questions

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section covers a summary of biochemistry and genetics.

Clinical Aspects of PDE in Current Perspectives and Questions

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section covers the clinical aspects of PDE.

The Three Forms of PDE in Current Perspectives and Questions

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section is on the three types of PDE.

Introduction to Current Perspectives and Questions

This is an introduction to an article that was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1).

Why Newborn Screening for Pyridoxine-Dependent Epilepsy is a Game-Changer

If you’re a parent or caregiver of a child with Pyridoxine-Dependent Epilepsy (PDE), you know how crucial early diagnosis and treatment are.

Understanding the Genetic Causes of PDE: Exploring the different types of mutations.

In this post, we will delve into the genetic underpinnings of PDE, shedding light on the diverse types of mutations associated with PDE.

© 2023 Cure PDE Foundation | All Rights Reserved | Terms of Use | Privacy Policy